Outcomes

Antidepressants and Weight Gain: Which Ones are the Worst Offenders?

Many women are understandably concerned about the risk of weight gain associated with antidepressants. It is difficult to advise them as to which antidepressants are less or more likely to cause weight gain, as there [...]

By |2014-06-15T21:22:16-04:00June 17th, 2014|Antidepressants, General, Outcomes|Comments Off on Antidepressants and Weight Gain: Which Ones are the Worst Offenders?

SSRIs and Chiari Malformations

A recent study from researchers at the University of North Carolina reports that the children of depressed mothers treated with selective serotonin reuptake inhibitors (SSRIs) during pregnancy were more likely to develop Chiari type 1 malformations than were the children of mothers with no history of depression.

By |2014-06-17T10:16:50-04:00June 16th, 2014|Antidepressants, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on SSRIs and Chiari Malformations

Pregnancy and Marijuana: How Much Do We Really Know?

With many states now considering the legalization of medical marijuana, there seems to be a growing sense that marijuana is relatively safe and may, in some cases, be more attractive or effective than traditional pharmacologic interventions.  We have witnessed this shift in attitude in our clinic, where many of our clinicians have been surprised to hear women ask questions about the dangers of using antidepressants and other medications during pregnancy while at the same time feeling relatively comfortable with their use of marijuana in the same setting.

By |2014-05-15T17:09:26-04:00May 15th, 2014|Cannabis, Outcomes, Perinatal Substance Use|Comments Off on Pregnancy and Marijuana: How Much Do We Really Know?

Latest News From the National Pregnancy Registry

We would like to thank you for your continuing support of the National Pregnancy Registry for Atypical Antipsychotics (NPRAA) at the Center for Women’s Mental Health at Massachusetts General Hospital. We are grateful for all the referrals made to the Registry as our numbers continue to grow every day. Given the Registry’s successful enrollment, we are pleased to announce our plan to release preliminary data at an upcoming conference in June, the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting.

By |2014-05-09T21:28:52-04:00May 5th, 2014|Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Latest News From the National Pregnancy Registry

Antidepressant Use Associated with Longer Duration of Breastfeeding

Data was presented at the 18th Perinatal Society of Australia and New Zealand (PSANZ) Annual Conference in Perth regarding the use of antidepressants among breastfeeding women. Analyzing the data from the Danish National Birth Cohort [...]

By |2015-07-09T11:39:07-04:00April 18th, 2014|Antidepressants, Breastfeeding & Medications, Outcomes, Postpartum Psychiatric Disorders|Comments Off on Antidepressant Use Associated with Longer Duration of Breastfeeding

Clinical Update 2014: Use of Methylphenidate During Pregnancy

For women with mild to moderate attention-deficit/hyperactivity disorder (ADHD) symptoms, we frequently recommend discontinuing medication and switching to a non-pharmacologic intervention.  Although these women might experience some decrease in their level of functioning, they typically [...]

By |2017-12-22T14:40:20-04:00March 19th, 2014|ADHD Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Clinical Update 2014: Use of Methylphenidate During Pregnancy

Understanding the Link Between Maternal Diet, Depression and Child Development

While the human brain continues develop throughout the first twenty or so years of life, the most vulnerable periods of brain development occur during pregnancy and the first 2 to 3 years of the child’s [...]

By |2014-03-13T09:26:59-04:00March 17th, 2014|Child Outcomes, Outcomes, Psychiatric Disorders During Pregnancy|Comments Off on Understanding the Link Between Maternal Diet, Depression and Child Development
Go to Top